• 제목/요약/키워드: Cholestatic hepatitis

검색결과 18건 처리시간 0.025초

최근 10년간(1988~1998) 경기지역 소아에서 A형 간염의 역학적 변화 및 임상에 관한 연구 (Epidemiological Changes and Clinical Features of Hepatitis A in Children, Living in Kyung-gi Province, Since 1988 to 1998)

  • 김현;김종현;김동언;허재균;이원배;서병규;강진한
    • Pediatric Infection and Vaccine
    • /
    • 제5권2호
    • /
    • pp.230-238
    • /
    • 1998
  • 목 적 : 오염된 식수나 음식물에 의하여 전파되는 A형 간염은 전세계적으로 과거에 비해 현저한 발생 감소를 보이고 있고 국내에서도 1980년대 중반 이후부터는 돌발적 유행 양상은 소실되었고 매우 적은 수의 산발적 발생안 보고 되고 있다. 그러나 최근에 와서 성인과 소아에서 A형 간염이 점차 증가하는 추세를 보이고 있어 저자들은 최근 10년간 경기지역의 15세 이하의 소아에서 A형 간염의 역학적 변화와 이들 환아의 임상적 특성에 관하여 연구를 실시하였다. 대상 및 방법 : 1988년 7월부터 1998년 8월까지 경기지역에 있는 가톨릭대학교 의과대학 성모자애병원, 성가병원, 의정부성모병원, 성인센트병원에 임원된 환아중 혈청학적으로 A형 간염으로 진단된 환아들의 의무기록을 통하여 후향적으로 A형 간염의 연별, 월별, 연령별, 성별 발생상태와 발생과 연관된 역학적 특성, 그리고 임상적 특성, 경과 및 합병증 등에 관하여 분석하였다. 결 과 : 1) 연구 기간동안 46명이 A형 간염으로 진단되었고, 이들 환아중 28명(60.1%)이 1998년에 집중적으로 발생되었다. 2) 이들 환아는 연중 3월에서 7월 사이에 주로 발생되었고 또한 10세 이상의 연령(37명, 80.4%)에서 발생되었으며 남녀비는 1.2:1.0이었다. 3) 연구 환아들 부모의 사회경제 및 교육 정도는 중등도 이하가 각각 97.8%. 87.0%으로 낮았다. 그리고 이들 환아는 원인이 뚜렷하지 않고 집단적 발생은 없었으나 2례에서 가족내 발생이 확인되었다. 4) 임상적으로 내원시 이들 환아의 주소는 구토 및 구역, 황달, 식욕부진, 경미한 발열, 권태감, 복통, 상기도증상, 소화장애, 짙은 소변, 두통, 설사의 순으로 호소하였고, 진찰소견상에서는 황달, 간비대, 우상복부 압통, 비장종괸, 좌하복부 압통의 순으로 이상 소견을 보였다. 5) 간기능 검사상 전례에서 비정상적인 소견과 담즙 정체성 간염의 소견이 관찰되었으나 이들 소견은 2~4주 사이에 정상화되었다. 또한 복부 초음파 및 간동위원소 검사상 당낭벽 비후, 간비대, 비장비대, 복수 등의 소견이 관찰되었다. 6) 이들 연구 환아들의 평균 임원일 수는 11.1일이었고 전례에서 합병증 없이 좋은 경과를 보였다. 결 론 : 최근 10년간 경기지역에서 A형 간염의 발생의 양상은 사회경제 및 교육 정도가 낮은 가정의 10세 이상의 연령 소아에서 1998년도에 집중적으로 발생되고 있음을 알 수 있었고, 전례에서 비정상적인 간기능 소견이 관찰되었고 다수에서 담즙 정체성 간염의 양상을 보였으나 합병증 없이 좋은 임상 경과가 있었음을 확인하였다.

  • PDF

Autoimmune Sclerosing Cholangitis in Children: A Prospective Case-Control Study

  • Kumar, Nagendra;Poddar, Ujjal;Yadav, Rajnikant;Lal, Hira;Pani, Krushna;Yachha, Surender Kumar;Srivastava, Anshu;Pandey, Rakesh
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제24권2호
    • /
    • pp.154-163
    • /
    • 2021
  • Purpose: In children overlap of autoimmune hepatitis (AIH) and primary sclerosing cholangitis is labelled as autoimmune sclerosing cholangitis (ASC). The only prospective pediatric study showed a high prevalence of ASC by using endoscopic retrograde cholangiopancreatography. Aims of our study were to find the prevalence of ASC by using magnetic resonance cholangiography (MRC) in AIH and in non-AIH cirrhosis and to compare clinical presentation and outcome of AIH and ASC. Methods: Prospectively we did MRC in 38 children with AIH (cases) and 19 disease controls (Wilson disease). Multiple biliary strictures with proximal dilatation on MRC were taken as definitive changes of ASC. Detail clinical, laboratory parameters, liver histopathology and treatment outcome were recorded. Results: The median age of cases was 11.5 (3-18) years, 22 (57.9%) were girls and 28 (73.7%) were diagnosed as type 1 AIH. MRC was done in 11 children (28.9%) at the time of diagnosis and in 27 (71.1%) after a median follow-up of 2.5 (0.3-10) years. Abnormal MRC changes were seen in 14/38 (36.8%) of AIH and 8/19 (42.1%) of controls. However, definite changes of ASC were present in four (10.5%) children in AIH and none in controls. None of the clinical, laboratory, histological parameters and treatment response were significantly different between ASC and AIH groups. Conclusion: The prevalence of ASC in children with AIH was just 10.5%. We suggest MRC in select group with cholestatic features, inflammatory bowel disease and in those who showed poor response to immunosuppression instead of all children with AIH.

Urosodeoxycholic Acid Therapy in a Child with Trimethoprim- Sulfamethoxazole-induced Vanishing Bile Duct Syndrome

  • Cho, Hyun Jeong;Jwa, Hye Jeong;Kim, Kyu Seon;Gang, Dae Yong;Kim, Jae Young
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제16권4호
    • /
    • pp.273-278
    • /
    • 2013
  • We present a case of a 7-year-old boy who had cholestasis after trimethoprim-sulfamethoxazole combination therapy. Liver biopsy was performed 36 days after the onset of jaundice because of no evidence of improving cholestasis. Liver histology revealed portal inflammation, bile plug, and biliary stasis around the central vein with the loss of the interlobular bile ducts. Immunohistochemical stains for cytokeratin 7 and 19 were negative. These findings were consistent with those of vanishing bile duct syndrome (VBDS). Chlestasis was progressively improved with dose increment of urosodeoxycholic acid from conventional to high dose. This is the first case report of trimethoprime-sulfamethoxazole associated VBDS in Korean children. The case suggests that differential diagnosis of VBDS should be considered in case of progressive cholestatic hepatitis with elevation of alkaline phosphatase and gamma-glutamyl transpeptidase after or during taking medicine to treat nonhepatobiliary diseases illness.

Benign Recurrent Intrahepatic Cholestasis Type 2 in Siblings with Novel ABCB11 Mutations

  • Sohn, Min Ji;Woo, Min Hyung;Seong, Moon-Woo;Park, Sung Sup;Kang, Gyeong Hoon;Moon, Jin Soo;Ko, Jae Sung
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제22권2호
    • /
    • pp.201-206
    • /
    • 2019
  • Benign recurrent intrahepatic cholestasis (BRIC), a rare cause of cholestasis, is characterized by recurrent episodes of cholestasis without permanent liver damage. BRIC type 2 (BRIC2) is an autosomal recessive disorder caused by ABCB11 mutations. A 6-year-old girl had recurrent episodes of jaundice. At two months of age, jaundice and hepatosplenomegaly developed. Liver function tests showed cholestatic hepatitis. A liver biopsy revealed diffuse giant cell transformation, bile duct paucity, intracytoplasmic cholestasis, and periportal fibrosis. An ABCB11 gene study revealed novel compound heterozygous mutations, including c.2075+3A>G in IVS17 and p.R1221K. Liver function test results were normal at 12 months of age. At six years of age, steatorrhea, jaundice, and pruritus developed. Liver function tests improved following administration of phenylbutyrate and rifampicin. Her younger brother developed jaundice at two months of age and his genetic tests revealed the same mutations as his sister. This is the first report of BRIC2 confirmed by ABCB11 mutations in Korean siblings.

1-naphthylisothiocyanate에 기인된 랫드의 간내성 담즙분비 정지에 대한 인진호(Artemisia messes-schmidiana var viridis)의 약리학적 효과 (Pharmacological effects of Artemisia messes-schmidiana var viridis on 1-naphthylisothiocyanate-induced intrahepatic cholestasis in rat)

  • 김길수;이병노;박준형
    • 대한수의학회지
    • /
    • 제35권3호
    • /
    • pp.481-488
    • /
    • 1995
  • In oriental folk medicine, Artemisia messes-schmidiana var viridis(Compositae) has been used for jaundice, hepatitis, diuretic and liver cirrhosis etc. 1-naphthylisothiocyanate(ANIT) has been used for more than 20 years as a model compound to study mechanisms of intrahepatic cholestasis in laboratory animals as rat and mouse. Various biochemical and morphological changes including biliary epithelial and parenchymal cell necrosis occur in the liver of animals treated with ANIT. The purposes of present study are to examine pharmacological effects of Artemisia messes-schmidiana var viridis water extract(AMWE) on alterations of secretion volume and total bile acids level in bile juice, and that of serum AST, ALT, ALP, bilirubin, and glucose levels in rat. AMWE stimulated bile secretion and recovered ANIT-induced cholestasis. Bile acid concentrations increased to more than 60% compared with normal by ANIT, which were returned toward normal value with AMWE treatment. Serum AST and ALT activities were increased by ANIT and yet which were significantly decreased with AMWE treatment. In addition, this effect was apparent in AMWE pretreatment group. Serum glucose levels were increased with AMWE and ANIT, while were decreased compared with control in AMWE posttreatment group. Increased serum total bilirubin contents and ALP activities by ANIT were significantly decreased with AMWE posttreatment. In conclusion, AMWE exerted bile acid-independent choleresis effect and then improved to normal conditions ANIT-induced cholestatic syndromes. Also, AMWE have protective and regenerative effect of hepatocytes in rat.

  • PDF

Novel Mutations in the CPT1A Gene Identified in the Patient Presenting Jaundice as the First Manifestation of Carnitine Palmitoyltransferase 1A Deficiency

  • Choi, Jong Sub;Yoo, Hyeoh Won;Lee, Kyung Jae;Ko, Jung Min;Moon, Jin Soo;Ko, Jae Sung
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제19권1호
    • /
    • pp.76-81
    • /
    • 2016
  • Carnitine palmitoyltransferase 1A (CPT1A) is an enzyme functioning in mitochondrial fatty acid oxidation (FAO) of the liver. Patients with CPT1A deficiency have impaired mitochondrial FAO and display hypoketotic hypoglycemia and hepatic encephalopathy as typical manifestations. In this report, we present a case of CPT1A deficiency presenting jaundice as the first manifestation. A 1.9 years old boy showed jaundice and elevated levels of free and total carnitine were observed. From direct sequencing analysis of CPT1A, two novel mutations, c.1163+1G>A and c.1393G>A (p.Gly465Arg), were identified. At the age of 2.2 years, hypoglycemia, tachycardia, and altered mental status developed just after cranioplasty for craniosynostosis. High glucose infusion rate was required for recovery of his vital signs and mentality. Diet rich in high carbohydrate, low fat and inclusion of medium chain triglyceride oil resulted in improvement in cholestatic hepatitis and since then the boy has shown normal growth velocity and developmental milestones to date.

Complete Recovery of Oxysterol 7α-Hydroxylase Deficiency by Living Donor Transplantation in a 4-Month-Old Infant: the First Korean Case Report and Literature Review

  • Hong, Jeana;Oh, Seak Hee;Yoo, Han-Wook;Nittono, Hiroshi;Kimura, Akihiko;Kim, Kyung Mo
    • Journal of Korean Medical Science
    • /
    • 제33권51호
    • /
    • pp.324.1-324.6
    • /
    • 2018
  • Oxysterol $7{\alpha}$-hydroxylase deficiency is a very rare liver disease categorized as inborn errors of bile acid synthesis, caused by CYP7B1 mutations. As it may cause rapid progression to end-stage liver disease even in early infancy, a high index of suspicion is required to prevent fatal outcomes. We describe the case of a 3-month-old boy with progressive cholestatic hepatitis and severe hepatic fibrosis. After excluding other etiologies for his early liver failure, we found that he had profuse urinary excretion of $3{\beta}$-monohydroxy-${\Delta}^5$-bile acid derivatives by gas chromatography/mass spectrometry analysis with dried urine spots on filter paper. He was confirmed to have a compound heterozygous mutation (p.Arg388Ter and p.Tyr469IlefsX5) of the CYP7B1 gene. After undergoing liver transplantation (LT) from his mother at 4 months of age, his deteriorated liver function completely normalized, and he had normal growth and development until the current follow-up at 33 months of age. We report the first Korean case of oxysterol $7{\alpha}$-hydroxylase deficiency in the youngest infant reported to undergo successful living donor LT to date.

소아에서 담췌관 질환에 대한 자기공명 담췌관조영술의 진단적 유용성 (The Usefulness of MRCP in the Evaluation of Pancreaticobiliary Diseases in Children)

  • 엄지현;이승연;정기섭
    • Clinical and Experimental Pediatrics
    • /
    • 제45권11호
    • /
    • pp.1381-1388
    • /
    • 2002
  • 목 적: MRCP는 간담도췌장 질환을 진단하는데 있어서 비침습적인 방법으로 매우 유용한 것으로 알려져 있다. 본 연구의 목적은 간담도췌장 질환이 의심되는 소아에서 MRCP의 진단적 유용성에 대해 알아보고자 한다. 방 법: 1996년 10월부터 2001년 5월까지 연세의대 세브란스병원 소아과에 간담도췌장 질환으로 입원하여 복부 초음파 및 MRCP를 시행한 환아 70례를 대상으로 하였다. 환아의 최종 진단은 수술, 조직검사 소견, 임상 소견, 기타 검사 등을 토대로 하였다. 결 과 : 1) 대상 환아는 총 70례로 남녀비는 1 : 1.2였으며 평균 연령은 $2.6{\pm}3.3$세였다. 2) 간기능 검사상 혈청 AST, ALT 치는 각각 $192.7{\pm}139.6IU/L$, $182.7{\pm}143.8IU/L$이었고, 총 빌리루빈치, 직접 빌리루빈치는 각각 $6.9{\pm}3.7mg/dll$, $4.8{\pm}2.4mg/dll$이었다. 3) 간담도 췌장질환의 원인은 담도폐쇄증 25례(35.7%), 신생아 간염 18례(25.7%), 담관낭종 16례(23%)로 이 중 APBDU를 동반한 경우가 7례(10.0%), APBDU를 동반하지 않은 경우가 6례(12.9%)였으며, 전염성 단핵구증, 전격성 간염, 콕시엘라증(coxiellosis) 등으로 인한 담즙 정체성 간염이 5례(7.1%), 경화성 담도염이 2례(2.8%), 이차성 담도 경화증은 1례(1.4%), 만성 재발성 췌장염 환아가 3례(4.3%)였다. 4) 수술 소견과 병리 조직학적 소견을 기준으로 할 때 간담도췌장질환에 대한 복부 초음파의 진단의 정확도 75.7%에 비해 MRCP는 97.1%로 높았다. MRCP의 예민도와 특이도는 담도폐쇄증의 경우 각각 100%, 98%였고, APBDU가 동반된 담관낭종의 경우 87.5%, 100%였으며, APBDU가 동반되지 않은 담관낭종, 경화성 담도염, 만성 반복성췌장염은 양자 모두 100%였다. 결 론 : 본 연구에서 MRCP는 간담도췌장 질환을 진단하는데 있어서 편리하고 안전하며 비침습적인 방법으로서 그 진단율 또한 다른 검사에 비해 뛰어나 소아에서 간담도췌장질환이 의심될 때 우선적으로 시행할 수 있는 매우 유용한 검사임을 알 수 있었다.